Literature DB >> 35212554

Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem.

Artur Fedorowski1,2, Fabrizio Ricci1,3,4, Viktor Hamrefors1,5, Kristin E Sandau6, Tae Hwan Chung7, James A S Muldowney8, Rakesh Gopinathannair9, Brian Olshansky10.   

Abstract

Orthostatic hypotension (OH), a common, often overlooked, disorder with many causes, is associated with debilitating symptoms, falls, syncope, cognitive impairment, and risk of death. Chronic OH, a cardinal sign of autonomic dysfunction, increases with advancing age and is commonly associated with neurodegenerative and autoimmune diseases, diabetes, hypertension, heart failure, and kidney failure. Management typically involves a multidisciplinary, patient-centered, approach to arrive at an appropriate underlying diagnosis that is causing OH, treating accompanying conditions, and providing individually tailored pharmacological and nonpharmacological treatment. We propose a novel streamlined pathophysiological classification of OH; review the relationship between the cardiovascular disease continuum and OH; discuss OH-mediated end-organ damage; provide diagnostic and therapeutic algorithms to guide clinical decision making and patient care; identify current gaps in knowledge and try to define future research directions. Using a case-based learning approach, specific clinical scenarios are presented highlighting various presentations of OH to provide a practical guide to evaluate and manage patients who have OH.

Entities:  

Keywords:  cardiovascular diseases; heart failure; hypertension; orthostatic hypotension; patient care

Mesh:

Year:  2022        PMID: 35212554      PMCID: PMC9049902          DOI: 10.1161/CIRCEP.121.010573

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  158 in total

1.  [Therapy of orthostatic disorders of cardiovascular regulation. Placebo controlled double-blind study with oxilofrine].

Authors:  K Pohl; W Kriech
Journal:  Fortschr Med       Date:  1991-11-20

2.  Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotension.

Authors:  Nazim Isma; Richard Sutton; Andreas Hillarp; Karin Strandberg; Olle Melander; Artur Fedorowski
Journal:  J Hypertens       Date:  2015-08       Impact factor: 4.844

3.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.

Authors:  Vincenza Spallone; Dan Ziegler; Roy Freeman; Luciano Bernardi; Simona Frontoni; Rodica Pop-Busui; Martin Stevens; Peter Kempler; Jannik Hilsted; Solomon Tesfaye; Phillip Low; Paul Valensi
Journal:  Diabetes Metab Res Rev       Date:  2011-10       Impact factor: 4.876

4.  Effects of atrial tachypacing on symptoms and blood pressure in severe orthostatic hypotension.

Authors:  Ritsuko Kohno; Haruhiko Abe; Yasushi Oginosawa; Toshihisa Nagatomo; Yutaka Otsuji
Journal:  Pacing Clin Electrophysiol       Date:  2007-01       Impact factor: 1.976

5.  Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.

Authors:  J Jankovic; J L Gilden; B C Hiner; H Kaufmann; D C Brown; C H Coghlan; M Rubin; F M Fouad-Tarazi
Journal:  Am J Med       Date:  1993-07       Impact factor: 4.965

6.  Therapeutic experience with fludrocortisone in diabetic postural hypotension.

Authors:  I W Campbell; D J Ewing; B F Clarke
Journal:  Br Med J       Date:  1976-04-10

7.  Orthostatic hypotension in genetically related hypertensive and normotensive individuals.

Authors:  Artur Fedorowski; Philippe Burri; Olle Melander
Journal:  J Hypertens       Date:  2009-05       Impact factor: 4.844

8.  Management of Orthostatic Hypotension, Postprandial Hypotension, and Supine Hypertension.

Authors:  Cyndya A Shibao; Italo Biaggioni
Journal:  Semin Neurol       Date:  2020-10-14       Impact factor: 3.420

9.  Pyridostigmine treatment trial in neurogenic orthostatic hypotension.

Authors:  Wolfgang Singer; Paola Sandroni; Tonette L Opfer-Gehrking; Guillermo A Suarez; Caroline M Klein; Stacy Hines; Peter C O'Brien; Jeffrey Slezak; Phillip A Low
Journal:  Arch Neurol       Date:  2006-02-13

10.  Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.

Authors:  Italo Biaggioni; Roy Freeman; Christopher J Mathias; Phillip Low; L Arthur Hewitt; Horacio Kaufmann
Journal:  Hypertension       Date:  2014-10-27       Impact factor: 10.190

View more
  1 in total

1.  Atrial Fibrillation as a Prognostic Indicator in Patients With Orthostatic Hypotension: Nationwide Inpatient Sample Analysis.

Authors:  Ahmed Brgdar; John Gharbin; Ahmad Awan; Richard Ogunti; Qasim Khurshid; Mayar Hamad; Prafulla Mehrotra
Journal:  Cardiol Res       Date:  2022-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.